FerioliM, CisterninoC, LeoV, PisaniL, PalangeP, NavaS. Protecting health care workers from SARS-CoV-2 infection: practical indications. Eur Respir Rev, 2020; 29(155):200068.
2.
TranK, CimonK, SevernM, Pessoa-SilvaCL, ConlyJ. Aerosol-generating procedures and risk of transmission of acute respiratory infections to health care workers: a systematic review. PLoS One, 2012; 7(4):e35797.
3.
SetoWH, TsangD, YungRW, ChingTY, NgTK, HoM, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet, 2003; 361(9368):1519-1520.
4.
GomersallCD, JoyntGM, HoOM, IpM, YapF, DerrickJL, et al. Transmission of SARS to health care workers. The experience of a Hong Kong ICU. Intensive Care Med, 2006; 32(4):564-569.
5.
ChanVW, NgHH, RahmanL, TangA, TangKP, MokA, et al. Transmission of severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2 during aerosol-generating procedures in critical care: a systematic review and meta-analysis of observational studies. Crit Care Med, 2021; 49(7):1159-1168.
6.
KlompasM, BakerM, RheeC. What Is an aerosol-generating procedure?. JAMA Surg, 2021; 156(2):113-114.
7.
FinkJB, EhrmannS, LiJ, DaileyP, McKiernanP, DarquenneC, et al. Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv, 2020; 33(6):300-304.
8.
JermyMC, SpenceCJT, KirtonR, O’DonnellJF, KabaliukN, GawS, et al. Assessment of dispersion of airborne particles of oral/nasal fluid by high-flow nasal cannula therapy. PLoS One, 2021; 16(2):e0246123.
9.
CazzolaM, OraJ, BiancoA, RoglianiP, MateraMG. Guidance on nebulization during the current COVID-19 pandemic. Respir Med, 2021; 176:106236.
10.
SethiS, BarjaktarevicIZ, TashkinDP. The use of nebulized pharmacotherapies during the COVID-19 pandemic. Ther Adv Respir Dis, 2020; 14:1753466620954366.
11.
GoldsteinKM, GhadimiK, MystakelisH, KongY, MengT, CantrellS, et al. Risk of transmitting coronavirus disease 2019 during nebulizer treatment: a systematic review. J Aerosol Med Pulm Drug Deliv, 2021; 34(3):155-170.
12.
LiJ, FinkJB. Narrative review of practical aspects of aerosol delivery via high-flow nasal cannula. Ann Transl Med, 2021; 9(7):590.
13.
McGrathJA, O’TooleC, BennettG, JoyceM, ByrneMA, MacLoughlinR. Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics, 2019; 11(6):254.
14.
HarnoisL, AlolaiwatA, JingG, FinkJB, DhandR, LiJ. Efficacy of various mitigation devices in reducing fugitive emissions from nebulizers. Respir Care, 2021; 67(4):394-403.
15.
LiJ, AlolaiwatA, HarnoisL, FinkJB, DhandR. Mitigating fugitive aerosols during aerosol delivery via high-flow nasal cannula devices. Respir Care, 2021; 67(4):404-414.
16.
Villarreal-FernandezE, PatelR, GolamariR, KhalidM, DeWatersA, HaouziP. A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19–associated respiratory failure. Crit Care, 2020; 24(1):337.
17.
LeeYH, ChoiKJ, ChoiSH, LeeSY, KimKC, KimEJ. Clinical significance of timing of intubation in critically ill patients with COVID-19: a multi-center retrospective study. J Clin Med, 2020; 9(9).
18.
Mellado-ArtigasR, FerreyroBL, AngrimanF, Hernandez-SanzM, ArrutiE, TorresA, et al. COVID-19 Spanish ICU Network. High-flow nasal oxygen in patients with COVID-19–associated acute respiratory failure. Crit Care, 2021; 25(1):58.
19.
PapoutsiE, GiannakoulisVG, XourgiaE, RoutsiC, KotanidouA, SiemposII. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of nonrandomized cohort studies. Crit Care, 2021; 25(1):121.
20.
TashkinDP, BarjaktarevicIZ. Nebulized treatments and the possible risk of coronavirus transmission: where is the evidence?. Chronic Obstr Pulm Dis, 2020; 7(3):136-138.
21.
LiJ, FinkJB, ElshafeiAA, StewartLM, BarbianHJ, MirzaSH, et al. Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res, 2021; 7(1):00519-2020.
22.
WallinM, TangP, ChangRYK, YangM, FinlayWH, ChanHK. Aerosol drug delivery to the lungs during nasal high-flow therapy: an in vitro study. BMC Pulm Med, 2019; 19(1):42.
23.
MyersTR. The science guiding selection of an aerosol delivery device. Respir Care, 2013; 58(11):1963-1973.
24.
NishimuraM. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care, 2016; 61(4):529-541.
25.
Ospina-TasconGA, Calderon-TapiaLE, GarciaAF, ZaramaV, Gomez-AlvarezF, Alvarez-SaaT, et al. HiFLo-Covid Investigators. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA, 2021; 326(21):2161-2171.
26.
BennettG, JoyceM, FernandezEF, MacLoughlinR. Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Med Exp, 2019; 7(1):20.
27.
MontielV, RobertA, RobertA, NabaouiA, MarieT, MestreNM, et al. Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure. Ann Intensive Care, 2020; 10(1):125.
28.
JinYH, HuangQ, WangYY, ZengXT, LuoLS, PanZY, et al. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19–infected health care workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey. Mil Med Res, 2020; 7(1):24.
